Focus: Nova Biomedical specializes in point-of-care (POC) sample analyzers and diagnostic devices for metabolic, cardiovascular, infectious disease, and oncology applications. The company operates as a focused medical device/diagnostics player headquartered in Waltham, MA.
Profile data last refreshed 2h ago · AI intelligence enriched 2mo ago
Stable — net +4 jobs in 30d
4 added, 0 removed. Backfill posture.
Nova Biomedical offers device/diagnostic domain expertise in established indications but presents limited growth hiring visibility and non-traditional pharma development pathways compared to integrated biotech.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Established POC glucose monitoring device with clinical validation in vulnerable neonatal populations.
Help build intelligence for Nova Biomedical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Nova Biomedical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Analytical platform for multi-marker diabetes assessment (HbA1c, lipids, UACR) in clinical settings.
Point-of-care renal biomarker device supporting both nephrology and oncology patient monitoring.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo